Allogeneic stem cells, on the other hand, are sourced from younger, healthy donors. These cells are typically more effective because they have not undergone the cellular degradation associated with aging, making them more potent for regenerative purposes. What are the benefits of using donor cells, and why are your own cells sometimes less effective? Donor cells, especially those sourced from younger, healthy individuals, are more robust and effective for regenerative therapies because they have not been subjected to the cellular degradation that occurs with aging. Younger donor cells have higher levels of regenerative potential, including better proliferation rates, stronger signaling capacity, and greater ability to support tissue repair. In contrast, autologous cells, particularly in older individuals, may be less effective due to age-related decline in cell functionality (called senescence). As cells age, their regenerative capabilities decrease, making them less efficient at supporting healing and recovery. Using allogeneic cells provides a way to bypass these limitations and deliver more potent regenerative effects. Do the MSCs at LMI require matching like blood types? No, the mesenchymal stem cells (MSCs) used at LMI do not require matching. These cells are immunologically privileged, meaning they can be safely used in various patients without triggering an immune response. This unique property ensures our therapies are both safe and effective for everyone we treat. Why don’t the MSCs used at LMI need matching? The MSCs we use at LMI naturally avoid detection by the immune system because they lack the markers that typically cause immune rejection. This allows them to integrate seamlessly into treatments without requiring genetic compatibility, providing a simpler and more efficient regenerative solution. What makes the MSCs at LMI unique? The MSCs used in LMI therapies are carefully sourced from young, healthy donors to maximize their regenerative potential. We maintain rigorous standards in processing and quality control to ensure their immunologically privileged status, delivering the highest level of effectiveness for tissue repair, anti-inflammatory action, and rejuvenation. Are there risks to using unmatched MSCs in LMI treatments? No, the unmatched MSCs we use at LMI have a very low risk of immune rejection due to their immunologically privileged nature. This makes them a safe and reliable choice for our regenerative medicine therapies. How do MSCs at LMI improve access to regenerative treatments? Since our MSCs do not require genetic matching, patients can begin their treatments without delay. This eliminates the need to search for a matched donor, ensuring faster and more accessible regenerative therapies at LMI.
© 2024 Longevity Medical Institute. All rights reserved.
5
Made with FlippingBook flipbook maker